Translational Research to Address Cancer Risk and Outcome: Pitfalls, Progress, and Purpose

The Miami CTSI invites you to join its Team Science Lecture Series virtually on Monday, September 15 at 4 p.m., as we present, “Translational Research to Address Cancer Risk and Outcome: Pitfalls, Progress, and Purpose,” presented by Erin Kobetz, Ph.D., M.P.H.

Register in Advance

Erin Kobetz, Ph.D., MPH

Dr. Erin Kobetz serves in multiple leadership roles at the University of Miami. As the first Vice President for Health Promotion and Chief Wellbeing Officer, she develops innovative strategies to improve health outcomes and expand access to quality healthcare for individuals across South Florida. In her role as the Associate Director for Community Outreach and Engagement at the Sylvester Comprehensive Cancer Center (SCCC), Dr. Kobetz oversees initiatives that deliver critical resources to broad communities.Dr. Kobetz also leads the Firefighter Cancer Initiative (FCI), a university-wide interdisciplinary program addressing the elevated cancer risks faced by firefighters. FCI combines research, education, and outreach to reduce occupational cancer risk through prevention strategies, early detection, and policy advocacy. In addition to her community-focused initiatives, Dr. Kobetz is a Multiple Principal Investigator and Co-Director of the University of Miami Clinical and Translational Science Institute (CTSI), where she promotes team science and stakeholder engagement. She is a Tenured Professor in the Departments of Medicine, Public Health Sciences, and Obstetrics and Gynecology at the Miller School of Medicine and holds the John K. and Judy H. Schulte Senior Endowed Chair in Cancer Research.